Inventor · disambiguated record
Eda Canales
Also filed as: CANALES EDA · CANALES EDA Y
35 granted patents·18 pending applications·475 citations·filing 2009–2025
98Inventor score
Top patents by PatentIndex Score
53 records- 0198US11753399B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2022·Granted Sep 12, 2023·7 cites·31 claims
- 0298US10947259B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Granted Mar 16, 2021·11 cites·4 claims
- 0398US8841278B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Sep 23, 2014·20 cites·7 claims
- 0498US8273341B2Antiviral compoundsGUO HONGYAN·Filed 2011·Granted Sep 25, 2012·47 cites·21 claims
- 0598US8088368B2Antiviral compoundsGUO HONGYAN·Filed 2010·Granted Jan 3, 2012·86 cites·23 claims
- 0697US11325930B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2021·Granted May 10, 2022·8 cites·4 claims
- 0797US11267801B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Granted Mar 8, 2022·4 cites·23 claims
- 0897US9951043B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2014·Granted Apr 24, 2018·36 cites·34 claims
- 0997US9873680B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2015·Granted Jan 23, 2018·26 cites·40 claims
- 1097US8822430B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2013·Granted Sep 2, 2014·17 cites·17 claims
- 1197US8575118B2Antiviral compoundsGUO HONGYAN·Filed 2012·Granted Nov 5, 2013·25 cites·4 claims
- 1296US10836746B2Therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Nov 17, 2020·20 cites·26 claims
- 1395US11878965B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Jan 23, 2024·4 cites·20 claims
- 1494US9511056B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2014·Granted Dec 6, 2016·7 cites·9 claims
- 1594US8884030B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Nov 11, 2014·29 cites·18 claims
- 1693US11976083B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted May 7, 2024·3 cites·15 claims
- 1793US8524764B2Inhibitors of Flaviviridae virusesCANALES EDA·Filed 2011·Granted Sep 3, 2013·29 cites·20 claims
- 1892US12091420B2SARS-COV2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Granted Sep 17, 2024·3 cites·28 claims
- 1992US9296782B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2013·Granted Mar 29, 2016·13 cites·16 claims
- 2092US8536187B22,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infectionsCANALES EDA·Filed 2009·Granted Sep 17, 2013·25 cites·23 claims
- 2190US12410183B2Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2024·Granted Sep 9, 2025·1 cites·25 claims
- 2290US8513298B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2011·Granted Aug 20, 2013·14 cites·2 claims
- 2389US12398160B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2023·Granted Aug 26, 2025·0 cites·2 claims
- 2488US9981955B2Antiviral compoundsGILEAD PHARMASSET LLC·Filed 2016·Granted May 29, 2018·2 cites·20 claims
- 2588US8569302B2Inhibitors of flaviviridae virusesCANALES EDA·Filed 2010·Granted Oct 29, 2013·14 cites·20 claims
- 2688US2025333428A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2025·Application pending·0 cites
- 2786US9321753B2Inhibitors of Flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Granted Apr 26, 2016·8 cites·19 claims
- 2883US11827662B2Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2022·Granted Nov 28, 2023·0 cites·2 claims
- 2983US10442804B2Compounds for the treatment of hepatitis B virus infectionGILEAD SCIENCES INC·Filed 2018·Granted Oct 15, 2019·4 cites·20 claims
- 3082US9655944B2Inhibitors of hepatitis C virusGILEAD SCIENCES INC·Filed 2016·Granted May 23, 2017·2 cites·2 claims
- 3182US8741946B2Inhibitors of flaviviridae virusesWATKINS WILLIAM J·Filed 2012·Granted Jun 3, 2014·9 cites·11 claims
- 3282US2024067629A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3380US10335409B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2018·Granted Jul 2, 2019·1 cites·2 claims
- 3475US2025049780A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3575US2024239807A1Sars-cov2 main protease inhibitorsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3673US12070455B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted Aug 27, 2024·0 cites·29 claims
- 3773US10603318B2Inhibitors of hepatitis C virusGILEAD PHARMASSET LLC·Filed 2019·Granted Mar 31, 2020·0 cites·2 claims
- 3873US2021061831A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 3973US2022259234A1Cot modulators and methods of use thereofGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 4069US11661431B2Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Granted May 30, 2023·0 cites·53 claims
- 4169US2023365594A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 4265US2021009555A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Application pending·0 cites
- 4364US2018273508A1Therapeutic compoundsGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 4461US2017290827A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2017·Application pending·0 cites
- 4558US12240862B2Inhibitors of peptidylarginine deiminasesGILEAD SCIENCES INC·Filed 2021·Granted Mar 4, 2025·0 cites·12 claims
- 4658US2024217990A1Thienopyrrole compoundsGILEAD SCIENCES INC·Filed 2022·Application pending·0 cites
- 4758US2016130300A1Inhibitors of hepatitis c virusGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4857US2024059673A1Substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 4957US2025002471A16-substituted indole compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 5052US2014030223A1Inhibitors of flaviviridae virusesGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Eda Canales files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →